Alexion Stock Soars (ALXN)

Shares of Alexion Pharmaceuticals (Nasdaq:ALXN) have taken a tremendous swing upward. The stock is trading at $122.74 as of 2:11 p.m. ET, 21% above Thursday's closing price of $101.44. Volume is at 2.6 million, 1.7 times the daily average of 1.5 million.
By TheStreet Wire ,

NEW YORK (

TheStreet

) -- Shares of

Alexion Pharmaceuticals

(Nasdaq:

ALXN

) have taken a tremendous swing upward. The stock is trading at $122.74 as of 2:11 p.m. ET, 21% above Thursday's closing price of $101.44. Volume is at 2.6 million, 1.7 times the daily average of 1.5 million.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Alexion has a market cap of $19.54 billion and is part of the health care sector and drugs industry. Shares are up 6.8% year to date as of the close of trading on Thursday.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-transforming therapeutic products.

TheStreet Ratings rates

Alexion

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full

Alexion Ratings Report

.

See our

top % gaining stocks list

for other stocks that are soaring today, or get investment ideas from our

investment research center

.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

.

null

Loading ...